跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NITRO-DUR 0.2 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NITRO-DUR 0.2
Authorized
STANDARD
NITRO-DUR 0.2
USPHARMA, LTD.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
82a94460069fdfa3
Company
USPHARMA, LTD.
Type
Standard
Approval Details
Approval Id
82a94460069fdfa3
Drug Approval Canada Name
NITRO-DUR 0.2
Product Name
NITRO-DUR 0.2
Status
Marketed
Status Date
2018-07-12
Original Market Date
1991-12-31
Din
01911910
Drug Class
Human
Dosage Form
Patch (Extended Release)
Route Of Administration
Transdermal
Schedule
Ethical
Ahfs
24:12.08
Atc Original
C01DA02 GLYCERYL TRINITRATE
Atc Name
c 01 da 02
Aig Number
0103615026
Company Name
USPHARMA, LTD.
Company Address
13900 Nw 57th Court, Miami, Florida, United States, 33014
Company Detail Path
/organization/uspharma-ltd
Company Information
Pharmaceutical Company Name
USPHARMA, LTD.
Country Name
United States
Province Name
Missouri
City Name
liberty,missouri,country_us
Address
115 Blue Jay Dr Ste 205
Active Ingredients
NITROGLYCERIN
0.2 MG / HOUR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
82a94460069fdfa3
Type
Standard
Back to Health Canada Approvals